Clinical Evaluation of Approved and Investigational Contact Lenses

Completed · Not applicable

Conditions studied: Visual Disorder

In brief

This study is a multi-site, 5-visit dispensing, bilateral double-arm parallel group design, double-masked clinical trial using an investigational contact lens and a marketed contact lens. The objective is to evaluate comfort of the contact lenses when worn on a daily wear modality.

Key facts

Study ID

NCT02669095

Run by

Johnson & Johnson Vision Care, Inc.

People needed

150

Starts

2016-01-01

Expected to finish

2016-03-01

Last updated by the study team

2017-06-09

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
• The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
• The subject must be between 18 to 40 years of age at the time of consent.
• The subject's vertexed spherical equivalent distance refraction must be in the range of +8.00 to -12.00 in each eye.
• Subject wears habitual contact lenses a minimum of 4 days per week, eight hours per day.
• The subject must have best corrected visual acuity of 20/30 or better in each eye.
• The subject must be a habitual frequent replacement daily wear spherical silicone hydrogel soft contact lens wearer in both eyes.
• The subject must be able to wear contact lenses for a minimum of 8 hours each day during the study.
• The subject must have normal eyes (i.e., no ocular medications or infections of any type).

You may not qualify if…

• Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued).
• Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
• Any systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear.
• Any known sensitive/allergic to Ingredients of OPTI-FREE® PureMoist® solution.
• Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or moderate or above corneal distortion.
• Any previous, or planned, ocular or interocular surgery (e.g., radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), etc.).
• Any grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale, any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that may contraindicate contact lens wear.
• Any ocular infection.
• Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
• Participation in any contact lens or lens care product clinical trial within 7 days prior to study enrollment.

Where it is running

• Golden Family Eyecare — Sarasota, Florida, United States
• Eye Associates of Winter Park — Winter Park, Florida, United States
• Pickens Family Eye Care — Pickens, South Carolina, United States
• Total Eye Care PA — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.